PRAME and neoplasm: PRAME (preferentially expressed antigen in melanoma; a.k.a. MAPE, OIP4, CT130) was identified as a gene encoding an HLA-A24-restricted peptide that stimulated tumor-specific cytotoxic T lymphocytes in a human melanoma cell line [6].